media

Markets

Market Nav

CASH FLOW

You can view the cash flow for the last 5 years.
Eris Lifesciences Ltd.
( in Crs.)

ParticularsMar 23Mar 22Mar 21Mar 20Mar 19
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue1.001.001.001.001.00
      
Net Profit/Loss Before Extraordinary Items And Tax404.64442.20394.50331.35317.36
      
Net CashFlow From Operating Activities291.74378.26375.36271.11223.00
Net Cash Used In Investing Activities-982.10-319.61-323.36123.29-5.05
Net Cash Used From Financing Activities688.03-44.70-82.40-334.59-221.05
Adjustments On Amalgamation / Merger / Demerger And Others7.490.000.000.000.00
      
Net Inc/Dec In Cash And Cash Equivalents5.1513.96-30.3959.81-3.11
Cash And Cash Equivalents Begin of Year50.8736.9267.317.5010.61
Cash And Cash Equivalents End Of Year56.0250.8736.9267.317.50
ParticularsMar 23
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue1.00
  
Net Profit/Loss Before Extraordinary Items And Tax404.64
Net CashFlow From Operating Activities291.74
Net Cash Used In Investing Activities-982.10
Net Cash Used From Financing Activities688.03
Adjustments On Amalgamation / Merger / Demerger And Others7.49
Net Inc/Dec In Cash And Cash Equivalents5.15
Cash And Cash Equivalents Begin of Year50.87
Cash And Cash Equivalents End Of Year56.02